Product Information
Registration Status: ActiveSIN02395P
ACTRAPID INJECTION 100 IU/ML is approved to be sold in Singapore with effective from 1988-11-24. It is marketed by NOVO NORDISK PHARMA (SINGAPORE) PTE LTD, with the registration number of SIN02395P.
This product contains Insulin Human (rDNA) 100IU/ml in the form of INJECTION. It is approved for INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR use.
This product is manufactured by Novo Nordisk A/S in FRANCE, andNovo Nordisk A/S in DENMARK.
It is a Pharmacy Only Medicine that can be obtained from a pharmacist at a retail pharmacy.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.